@article{CJCR905,
author = {Zhao-sheng Li and Lu Yao and Yi-qiang Liu and Tao Ouyang and Jin-feng Li and Tian-feng Wang and Zhao-qing Fan and Tie Fan and Ben-yao Lin and Yun-tao Xie},
title = {Breast Cancer Subtypes and Survival in Chinese Women with Operable Primary Breast Cancer},
journal = {Chinese Journal of Cancer Research},
volume = {23},
number = {2},
year = {2012},
keywords = {},
abstract = {Objective: To investigate the associations between the different breast cancer subtypes and survival in Chinese women with operable primary breast cancer.
Methods: A total of 1538 Chinese women with operable primary breast cancer were analyzed in this study, the median follow-up was 77 months. Estrogen receptor (ER), progesterone receptor (PR), and HER2 status were available for these patients.
Results: Luminal A (ER+ and/or PR+, HER2-) had a favorable disease-free survival (DFS) and overall survival (OS) compared with other subtypes in the entire cohort. Using the luminal A as a reference, among the patients with lymph node positive disease, HER2+ (ER-, PR-, HER2+) had the worst DFS (hazard ratio, HR=1.80, 95% CI 1.11 to 2.91, P=0.017) and luminal B (ER+ and/or PR+, HER2+) had the worst OS (HR=2.27, 95% CI 1.50 to 3.45, P},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/905}
}